About

Pancreatic cancer has the highest mortality rate of all major cancers. Approximately 94% of pancreatic cancer patients will die within five years of diagnosis, only 6% survive more than five years, and 74% of patients are lost within the first year of diagnosis. The Rolfe Pancreatic Cancer Foundation is a public charity dedicated to changing these statistics. It is our mission to serve as a catalyst for the early detection and ultimate cure of pancreatic cancer.


Just as colonoscopies, mammograms, and PSA tests have drastically increased the odds of patients confronting prostate, breast and colon cancer, the Rolfe Pancreatic Cancer Foundation is working toward the discovery of an early detection test that will improve the survival rates of patients facing pancreatic cancer.

The discovery of an early detection test will be the wave that turns the tide in the fight against pancreatic cancer. Unfortunately, it is a sad fact that federal funding for pancreatic cancer research is low, which makes the Rolfe Pancreatic Cancer Foundation’s work all the more important.

To date, the Foundation has raised over $6,000,000, and provided funding for pancreatic cancer research at Johns Hopkins and University of Chicago, while also providing resources to patients and their loved ones.